These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36701520)

  • 1. Utility of the 5-trial adjusting delay task in screening for high delay discounting rates: A cohort study of individuals reporting harmful alcohol and tobacco use.
    Dwyer CL; Craft WH; Tegge AN; Yeh YH; Bickel WK
    Exp Clin Psychopharmacol; 2023 Aug; 31(4):786-792. PubMed ID: 36701520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synergistic effect of cigarette demand and delay discounting on nicotine dependence among treatment-seeking smokers.
    Weidberg S; Secades-Villa R; García-Pérez Á; González-Roz A; Fernández-Hermida JR
    Exp Clin Psychopharmacol; 2019 Apr; 27(2):146-152. PubMed ID: 30570273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a Brief Measure of Delay Discounting to Examine the Relationship Between Delay Discounting and the Initiation of Substance Use Among Adolescents.
    Richardson CG; Edalati H
    Subst Use Misuse; 2016; 51(4):540-4. PubMed ID: 26943476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between parental history and delay discounting among individuals in recovery from addiction.
    Athamneh LN; Stein JS; Quisenberry AJ; Pope D; Bickel WK
    Drug Alcohol Depend; 2017 Oct; 179():153-158. PubMed ID: 28780380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative assessment of psychometric performance on the adjusting amounts versus the 21-item Monetary Choice Delay Discounting tasks among young adult substance users.
    González-Roz A; Martínez-Loredo V; Postigo Á; Yoon JH
    Exp Clin Psychopharmacol; 2024 Jun; 32(3):358-368. PubMed ID: 38010762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discounting of delayed monetary and cannabis rewards in a crowdsourced sample of adults.
    Patel H; Naish KR; Amlung M
    Exp Clin Psychopharmacol; 2020 Aug; 28(4):462-470. PubMed ID: 31621347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Phenotype of Recovery X: Associations between delay discounting, regulatory flexibility, and remission from substance use disorder.
    Dwyer CL; Tegge AN; Craft WH; Tomlinson DC; Athamneh LN; Bickel WK
    J Subst Use Addict Treat; 2023 Dec; 155():209122. PubMed ID: 37451516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of cross-commodity delay discounting research with relevance to addiction.
    Pritschmann RK; Yurasek AM; Yi R
    Behav Processes; 2021 May; 186():104339. PubMed ID: 33545318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phenotype of recovery III: Delay discounting predicts abstinence self-efficacy among individuals in recovery from substance use disorders.
    Athamneh LN; DeHart WB; Pope D; Mellis AM; Snider SE; Kaplan BA; Bickel WK
    Psychol Addict Behav; 2019 May; 33(3):310-317. PubMed ID: 30896193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationships among parental family history of substance misuse, delay discounting, and personal substance use.
    VanderBroek L; Acker J; Palmer AA; de Wit H; MacKillop J
    Psychopharmacology (Berl); 2016 Jan; 233(1):39-48. PubMed ID: 26395990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between delay discounting and Internet addiction: A systematic review and meta-analysis.
    Cheng YS; Ko HC; Sun CK; Yeh PY
    Addict Behav; 2021 Mar; 114():106751. PubMed ID: 33310692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valuation of future alcohol in cross-commodity delay discounting is associated with alcohol misuse/consequences.
    Taylor H; Smith AP; Yi R
    Psychol Addict Behav; 2023 Feb; 37(1):166-176. PubMed ID: 35737549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive roles of tobacco and cannabis co-use in relation to delay discounting in a sample of heavy drinkers.
    Nieto SJ; Venegas A; Burnette EM; MacKillop J; Ray LA
    Psychopharmacology (Berl); 2022 May; 239(5):1387-1395. PubMed ID: 34652499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol pre-exposure does not increase delay discounting in P rats, but does impair the ability to dynamically adapt behavioral allocation to changing reinforcer contingencies.
    Beckwith SW; Czachowski CL
    Pharmacol Biochem Behav; 2019 Dec; 187():172816. PubMed ID: 31654652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phenotype of recovery VIII: Association among delay discounting, recovery capital, and length of abstinence among individuals in recovery from substance use disorders.
    Keith DR; Tegge AN; Athamneh LN; Freitas-Lemos R; Tomlinson DC; Craft WH; Bickel WK
    J Subst Abuse Treat; 2022 Aug; 139():108783. PubMed ID: 35562317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a cortical delay discounting assay: a potential biomarker of externalizing disorders.
    Sadeh N; Miglin R; Bounoua N; Sheehan A; Spielberg JM
    Psychol Med; 2023 Mar; 53(4):1143-1150. PubMed ID: 34167611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in associations between delay discounting and expectancies for alcohol analgesia.
    Ferguson E; Vitus D; Williams M; Anderson M; LaRowe L; Ditre JW; Stennett B; Boissoneault J
    Exp Clin Psychopharmacol; 2022 Dec; 30(6):862-872. PubMed ID: 34410797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of delay discounting and drinking trajectories from ages 14 to 22.
    Fröhner JH; Ripke S; Jurk S; Li SC; Banaschewski T; Bokde ALW; Quinlan EB; Desrivières S; Flor H; Grigis A; Garavan H; Heinz A; Brühl R; Martinot JL; Paillère Martinot ML; Artiges E; Nees F; Papadopoulos Orfanos D; Poustka L; Hohmann S; Walter H; Whelan R; Schumann G; Smolka MN;
    Alcohol Clin Exp Res; 2022 Apr; 46(4):667-681. PubMed ID: 35257381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phenotype of recovery VII: Delay discounting mediates the relationship between time in recovery and recovery progress.
    Craft WH; Tegge AN; Athamneh LN; Tomlinson DC; Freitas-Lemos R; Bickel WK
    J Subst Abuse Treat; 2022 May; 136():108665. PubMed ID: 34895955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the utility of a novel cortical marker of delay discounting (C-DD) in two independent samples of early adolescents: Links with externalizing pathology.
    Bounoua N; Church LD; Matyi MA; Rudoler J; Wieand K; Spielberg JM
    PLoS One; 2023; 18(9):e0291868. PubMed ID: 37756262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.